Mars Acquires Cerba HealthCare's Stake in Cerba Vet and ANTAGENE
July 2, 2024
Mars, Incorporated has completed its acquisition of Cerba HealthCare's ownership stake in French veterinary diagnostics businesses Cerba Vet and ANTAGENE. The two businesses will join Mars Petcare's Science & Diagnostics division to complement its existing veterinary diagnostics and genetic testing capabilities.
- Buyers
- Mars, Incorporated
- Targets
- Cerba Vet, ANTAGENE
- Sellers
- Cerba HealthCare
- Industry
- Healthcare Services
- Location
- France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Merck Animal Health (MSD Animal Health) to Acquire TARGAN
June 12, 2026
Healthcare Services
Merck Animal Health has signed a definitive agreement to acquire TARGAN, a privately held poultry animal-agriculture technology company developing biodevice solutions. The deal is expected to close in the third quarter of 2026, subject to regulatory approvals and customary closing conditions.
-
Nextmune Acquires VetBiotek
December 22, 2023
Veterinary
Nextmune, a global specialty animal-health company, acquired VetBiotek, a developer of veterinary dermatology topical formulations including MicroSilver BG and Ceramide III products. The acquisition expands Nextmune’s dermatology portfolio and aims to improve production, packaging, distribution and access of VetBiotek’s products to veterinary clinics and distributors.
-
Gryphon Investors Acquires Vetnique Labs
April 20, 2023
Consumer Products
Gryphon Investors, a San Francisco-based private equity firm, has acquired Vetnique Labs, a Naperville, Illinois-based pet health and wellness company. Gryphon will partner with founder and CEO James Bascharon (who will remain in role and retain a significant stake) to expand Vetnique’s product portfolio and geographic reach; financial terms were not disclosed.
-
Mars, Incorporated to Acquire Heska Corporation
April 3, 2023
Healthcare Services
Mars, Incorporated entered into a definitive agreement to acquire Heska Corporation, a global provider of advanced veterinary diagnostic and specialty products, for $120.00 per share. The deal is intended to expand Mars Petcare’s Science & Diagnostics capabilities and broaden point-of-care veterinary diagnostic offerings, with closing anticipated in the second half of 2023.
-
Mars Petcare Acquires Champion Petfoods (ORIJEN & ACANA)
November 1, 2022
Food & Beverage
Mars Petcare (part of Mars, Incorporated) has signed a definitive agreement to acquire Champion Petfoods, the Edmonton-based maker of premium pet food brands ORIJEN and ACANA, from an investor group led by Bedford Capital and the Healthcare of Ontario Pension Plan. The undisclosed-value transaction — which brings Champion's more than 800 employees into the Mars Petcare family — is expected to close in the first half of 2023 and will expand Mars' premium pet nutrition portfolio and global distribution footprint.
-
Merck Animal Health Acquires Vence
September 22, 2022
AI & Machine Learning
Merck Animal Health (a division of Merck & Co., Inc.) signed a definitive agreement to acquire Vence from its founders and shareholders. The acquisition will expand Merck Animal Health’s animal intelligence and virtual fencing technology portfolio for cattle producers and ranchers, and is expected to close in Q3 2022 subject to customary conditions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.